Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock, Par Value $0.01 per share
-
Shares outstanding
-
162M
-
Number of holders
-
197
-
Total 13F shares, excl. options
-
56.1M
-
Shares change
-
-3.17M
-
Total reported value, excl. options
-
$417M
-
Value change
-
-$21.7M
-
Put/Call ratio
-
1.6
-
Number of buys
-
92
-
Number of sells
-
-83
-
Price
-
$7.43
Significant Holders of NOVAVAX INC - Common Stock, Par Value $0.01 per share (NVAX) as of Q2 2023
283 filings reported holding NVAX - NOVAVAX INC - Common Stock, Par Value $0.01 per share as of Q2 2023.
NOVAVAX INC - Common Stock, Par Value $0.01 per share (NVAX) has 197 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 56.1M shares
of 162M outstanding shares and own 34.66% of the company stock.
Largest 10 shareholders include STATE STREET CORP (11.7M shares), VANGUARD GROUP INC (10.6M shares), BlackRock Inc. (6.99M shares), SHAH CAPITAL MANAGEMENT (5.48M shares), BANK OF AMERICA CORP /DE/ (2.18M shares), MORGAN STANLEY (2.08M shares), GEODE CAPITAL MANAGEMENT, LLC (1.74M shares), Rafferty Asset Management, LLC (1.11M shares), COATUE MANAGEMENT LLC (1.04M shares), and NORTHERN TRUST CORP (870K shares).
This table shows the top 197 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.